Microglial-glucocorticoid receptor depletion alters the response of hippocampal microglia and neurons in a chronic unpredictable mild stress paradigm in female mice.


Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
10 2021
Historique:
received: 20 11 2020
revised: 23 07 2021
accepted: 28 07 2021
pubmed: 4 8 2021
medline: 23 9 2021
entrez: 3 8 2021
Statut: ppublish

Résumé

Chronic psychological stress is one of the most important triggers and environmental risk factors for neuropsychiatric disorders. Chronic stress can influence all organs via the secretion of stress hormones, including glucocorticoids by the adrenal glands, which coordinate the stress response across the body. In the brain, glucocorticoid receptors (GR) are expressed by various cell types including microglia, which are its resident immune cells regulating stress-induced inflammatory processes. To study the roles of microglial GR under normal homeostatic conditions and following chronic stress, we generated a mouse model in which the GR gene is depleted in microglia specifically at adulthood to prevent developmental confounds. We first confirmed that microglia were depleted in GR in our model in males and females among the cingulate cortex and the hippocampus, both stress-sensitive brain regions. Then, cohorts of microglial-GR depleted and wild-type (WT) adult female mice were housed for 3 weeks in a standard or stressful condition, using a chronic unpredictable mild stress (CUMS) paradigm. CUMS induced stress-related behavior in both microglial-GR depleted and WT animals as demonstrated by a decrease of both saccharine preference and progressive ratio breakpoint. Nevertheless, the hippocampal microglial and neural mechanisms underlying the adaptation to stress occurred differently between the two genotypes. Upon CUMS exposure, microglial morphology was altered in the WT controls, without any apparent effect in microglial-GR depleted mice. Furthermore, in the standard environment condition, GR depleted-microglia showed increased expression of pro-inflammatory genes, and genes involved in microglial homeostatic functions (such as Trem2, Cx3cr1 and Mertk). On the contrary, in CUMS condition, GR depleted-microglia showed reduced expression levels of pro-inflammatory genes and increased neuroprotective as well as anti-inflammatory genes compared to WT-microglia. Moreover, in microglial-GR depleted mice, but not in WT mice, CUMS led to a significant reduction of CA1 long-term potentiation and paired-pulse ratio. Lastly, differences in adult hippocampal neurogenesis were observed between the genotypes during normal homeostatic conditions, with microglial-GR deficiency increasing the formation of newborn neurons in the dentate gyrus subgranular zone independently from stress exposure. Together, these findings indicate that, although the deletion of microglial GR did not prevent the animal's ability to respond to stress, it contributed to modulating hippocampal functions in both standard and stressful conditions, notably by shaping the microglial response to chronic stress.

Identifiants

pubmed: 34343616
pii: S0889-1591(21)00286-5
doi: 10.1016/j.bbi.2021.07.022
pii:
doi:

Substances chimiques

Membrane Glycoproteins 0
Receptors, Glucocorticoid 0
Receptors, Immunologic 0
Trem2 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

423-439

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Katherine Picard (K)

Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada; Molecular Medicine Department, Université Laval, Québec City, QC, Canada; Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.

Kanchan Bisht (K)

Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.

Silvia Poggini (S)

Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.

Stefano Garofalo (S)

Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.

Maria Teresa Golia (MT)

Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.

Bernadette Basilico (B)

Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy; Institute of Science and Technology (IST) Austria, Klosterneuburg, Austria.

Fatima Abdallah (F)

Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.

Naomi Ciano Albanese (N)

Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy; Institute of Science and Technology (IST) Austria, Klosterneuburg, Austria.

Irmgard Amrein (I)

Functional Neuroanatomy, Institute of Anatomy, University of Zürich, Zurich, Switzerland.

Nathalie Vernoux (N)

Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.

Kaushik Sharma (K)

Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.

Chin Wai Hui (CW)

Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.

Julie C Savage (J)

Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.

Cristina Limatola (C)

Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy; IRCCS Neuromed, Pozzilli, Italy.

Davide Ragozzino (D)

Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.

Laura Maggi (L)

Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.

Igor Branchi (I)

Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.

Marie-Ève Tremblay (MÈ)

Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada; Molecular Medicine Department, Université Laval, Québec City, QC, Canada; Division of Medical Sciences, University of Victoria, Victoria, BC, Canada; The Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, BC, Canada. Electronic address: evetremblay@uvic.ca.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH